发明授权
US08604034B2 Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections
有权
用于治疗呼吸道合胞病毒（RSV）感染的取代的咪唑并[1,2-α]吡咯并[1,2-d]吡嗪
![Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections](/docs/US/2013-12-10/US08604034B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections
- 专利标题（中）： 用于治疗呼吸道合胞病毒（RSV）感染的取代的咪唑并[1,2-α]吡咯并[1,2-d]吡嗪
-
申请号： US13023473申请日： 2011-02-08
-
公开(公告)号： US08604034B2公开(公告)日： 2013-12-10
- 发明人: Jeffrey Peter Mitchell , Gary Pitt , Alistair George Draffan , Penelope Anne Mayes , Laura Andrau , Kelly Anderson
- 申请人： Jeffrey Peter Mitchell , Gary Pitt , Alistair George Draffan , Penelope Anne Mayes , Laura Andrau , Kelly Anderson
- 申请人地址： AU Notting Hill, Victoria
- 专利权人： Biota Scientific Management Pty Ltd.
- 当前专利权人： Biota Scientific Management Pty Ltd.
- 当前专利权人地址： AU Notting Hill, Victoria
- 代理机构： Klarquist Sparkman, LLP
- 优先权： AU2010900494 20100208
- 主分类号： A61K31/495
- IPC分类号： A61K31/495
![Substituted imidazo[1,2-α]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus (RSV) infections](/abs-image/US/2013/12/10/US08604034B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.
公开/授权文献
信息查询
